CTOs on the Move

Everest Medicines

www.everestmedicines.com

 
Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients in mainland China and other Asian territories. We strive to be the partner of choice for innovative companies around the world with products that address critical unmet medical needs for patients in Greater China and have a high probability of market approval. The Everest Medicines team has deep expertise and extensive track record of high quality clinical development, regulatory affairs, CMC, business development and operations both in China and with leading global pharmaceutical companies. The company`s Series A round was led by C-Bridge ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Mike Berry
 Chief Technology Officer Profile

Funding

Everest Medicines raised $310M on 06/03/2020

Similar Companies

Pharmetics

Pharmetics is a Laval, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Fruth Pharmacy

Fruth Pharmacy has been serving Southwestern West Virginia and Southern Ohio Since 1952. We cater to the needs of our customers by providing the best customer service in town. Fruth's pharmacists are on duty 7 days a week and are dedicated to serving

Mcneil-ppc Inc

Mcneil-ppc Inc is a Lititz, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Innova Primary Care

Innova Primary Care - Mending Standards. Mending People.

Pieris

Pieris Pharmaceuticals is a clinical stage biotechnology company that discovers and develops Anticalin-based drugs to target validated disease pathways in a unique and transformative way. Our pipeline includes immuno-oncology multi-specifics tailored for the tumor micro-environment, an inhaled Anticalin to treat uncontrolled asthma and a half-life-optimized Anticalin to treat anemia. Proprietary to Pieris, Anticalin proteins are a novel class of therapeutics validated in the clinic and by partnerships with leading pharmaceutical companies. Pieris is listed on the NASDAQ and trades under the ticker symbol PIRS.